Class 3 Falsified Medicines Directive (FMD) recall – Beconase Aqueous Nasal Spray 50mcg
12th February 2020
Class 3 Falsified Medicines Directive (FMD) recall – Action within 5 days – Beconase Aqueous Nasal Spray 50mcg
Ref: EL (20)A/07
12 February 2020
Beconase (beclometasone dipropionate) Aqueous nasal spray 50mcg
(Manufactured by Glaxo Wellcome UK Ltd T/A GSK)
A Class 3 FMD recall has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for a specific batch of Beconase Aqueous nasal spray due to an error upon decommissioning.
||6 January 2020
Further information can be found on the MHRA section on the GOV.UK website.
Produced by the NPA Pharmacy Services team February 2020